ACM

Aisling Capital Management Portfolio holdings

AUM $360M
This Quarter Return
-3.25%
1 Year Return
+114.67%
3 Year Return
+1,171.46%
5 Year Return
+892.24%
10 Year Return
AUM
$140M
AUM Growth
+$140M
Cap. Flow
-$18.1M
Cap. Flow %
-12.92%
Top 10 Hldgs %
93.49%
Holding
21
New
Increased
Reduced
2
Closed
2
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
BBIO icon
1
BridgeBio Pharma
BBIO
$9.89B
$55.1M 39.31%
6,068,125
SNDX icon
2
Syndax Pharmaceuticals
SNDX
$1.41B
$19.7M 14.07%
1,025,000
GLUE icon
3
Monte Rosa Therapeutics
GLUE
$296M
$14.2M 10.16%
1,472,331
BMEA icon
4
Biomea Fusion
BMEA
$116M
$9.57M 6.83%
798,757
ACRS icon
5
Aclaris Therapeutics
ACRS
$209M
$8.86M 6.32%
634,455
NUVB icon
6
Nuvation Bio
NUVB
$1.02B
$8.23M 5.87%
2,541,009
VRNA
7
Verona Pharma
VRNA
$9.16B
$5.58M 3.98%
1,332,485
ELEV
8
DELISTED
Elevation Oncology
ELEV
$3.97M 2.83%
2,834,910
TRML icon
9
Tourmaline Bio
TRML
$601M
$3.08M 2.2%
682,923
PSTX
10
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$2.69M 1.92%
1,043,267
OKUR
11
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$37.2M
$2.35M 1.68%
886,075
SPRB
12
DELISTED
Spruce Biosciences, Inc. Common Stock
SPRB
$2.1M 1.5%
1,205,511
VIRX
13
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$1.12M 0.8%
288,571
MRKR icon
14
Marker Therapeutics
MRKR
$12M
$1.04M 0.74%
3,142,857
TECX
15
Tectonic Therapeutic, Inc. Common Stock
TECX
$478M
$929K 0.66%
1,009,779
SYRE icon
16
Spyre Therapeutics
SYRE
$996M
$854K 0.61%
1,691,151
BCEL
17
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$694K 0.5%
387,653
ZSAN
18
DELISTED
Zosano Pharma Corporation
ZSAN
$24K 0.02%
77,663
-2,640,563
-97% -$816K
NBRV
19
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$16K 0.01%
90,000
-101,028
-53% -$18K
HRMY icon
20
Harmony Biosciences
HRMY
$2.12B
-342,815
Closed -$16.7M
OBSV
21
DELISTED
ObsEva SA Ordinary Shares
OBSV
-394,838
Closed -$596K